Translational molecular imaging in exocrine pancreatic cancer
Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancer cases. Late diagnosis and failure of chemo- and radiotherapy are all too common, and many patients die soon afte...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Springer
2018
|
| _version_ | 1797094639826632704 |
|---|---|
| author | Cornelissen, B Knight, J Mukherjee, S Evangelista, L Xavier, C Caobelli, F Del Vecchio, S Rbah-Vidal, L Barbet, J De Jong, M Van Leeuwen, F |
| author_facet | Cornelissen, B Knight, J Mukherjee, S Evangelista, L Xavier, C Caobelli, F Del Vecchio, S Rbah-Vidal, L Barbet, J De Jong, M Van Leeuwen, F |
| author_sort | Cornelissen, B |
| collection | OXFORD |
| description | Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancer cases. Late diagnosis and failure of chemo- and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we will make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management. |
| first_indexed | 2024-03-07T04:16:47Z |
| format | Journal article |
| id | oxford-uuid:c9aaba15-d8e2-4246-a5bf-6b1c20df1949 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T04:16:47Z |
| publishDate | 2018 |
| publisher | Springer |
| record_format | dspace |
| spelling | oxford-uuid:c9aaba15-d8e2-4246-a5bf-6b1c20df19492022-03-27T07:01:09ZTranslational molecular imaging in exocrine pancreatic cancerJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c9aaba15-d8e2-4246-a5bf-6b1c20df1949Symplectic Elements at OxfordSpringer2018Cornelissen, BKnight, JMukherjee, SEvangelista, LXavier, CCaobelli, FDel Vecchio, SRbah-Vidal, LBarbet, JDe Jong, MVan Leeuwen, FEffective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancer cases. Late diagnosis and failure of chemo- and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we will make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management. |
| spellingShingle | Cornelissen, B Knight, J Mukherjee, S Evangelista, L Xavier, C Caobelli, F Del Vecchio, S Rbah-Vidal, L Barbet, J De Jong, M Van Leeuwen, F Translational molecular imaging in exocrine pancreatic cancer |
| title | Translational molecular imaging in exocrine pancreatic cancer |
| title_full | Translational molecular imaging in exocrine pancreatic cancer |
| title_fullStr | Translational molecular imaging in exocrine pancreatic cancer |
| title_full_unstemmed | Translational molecular imaging in exocrine pancreatic cancer |
| title_short | Translational molecular imaging in exocrine pancreatic cancer |
| title_sort | translational molecular imaging in exocrine pancreatic cancer |
| work_keys_str_mv | AT cornelissenb translationalmolecularimaginginexocrinepancreaticcancer AT knightj translationalmolecularimaginginexocrinepancreaticcancer AT mukherjees translationalmolecularimaginginexocrinepancreaticcancer AT evangelistal translationalmolecularimaginginexocrinepancreaticcancer AT xavierc translationalmolecularimaginginexocrinepancreaticcancer AT caobellif translationalmolecularimaginginexocrinepancreaticcancer AT delvecchios translationalmolecularimaginginexocrinepancreaticcancer AT rbahvidall translationalmolecularimaginginexocrinepancreaticcancer AT barbetj translationalmolecularimaginginexocrinepancreaticcancer AT dejongm translationalmolecularimaginginexocrinepancreaticcancer AT vanleeuwenf translationalmolecularimaginginexocrinepancreaticcancer |